Quality of evidence considered by Health Canada in granting full market authorisation to new drugs with a conditional approval: a retrospective cohort study

OBJECTIVES: This study examines the characteristics of studies that Health Canada uses to grant full marketing authorisation for products given a conditional approval between 1 January 1998 and 30 June 2017. DESIGN: Cohort study. DATA SOURCES: Journal articles listing drugs that fulfilled their cond...

Descripción completa

Detalles Bibliográficos
Autor principal: Lexchin, Joel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2018
Materias:
Health Policy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931291/
https://www.ncbi.nlm.nih.gov/pubmed/29705760
http://dx.doi.org/10.1136/bmjopen-2017-020377

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5931291/
https://www.ncbi.nlm.nih.gov/pubmed/29705760
http://dx.doi.org/10.1136/bmjopen-2017-020377

Ejemplares similares